What’s the reason behind IMNM stock’s rapid increase?
Immunome, a biopharmaceutical company, has recently claimed that they have isolated an antibody that is highly effective against SARS-CoV-2 variants. Immunome stock climbed higher in the market after their press release and the share volume increased from 117,600 shares to 506,600 shares. Immunome is a biopharmaceutical company that makes use of human memory B cells […]